Form 4: Pharvaris Executive Sells Shares
Insider Transaction (Form 4)
Anne Lesage, Chief Early Development of Pharvaris N.V., sold 30,000 shares of common stock on September 10, 2026 for $38.30 per share.
Summary
- Option exercise/conversion: acquired 30,000 Common Stock at $8.05 ($241,500) on September 10, 2026; holds 86,450 after (Direct).
- Open-market sale: disposed of 30,000 Common Stock at $38.30 ($1,149,084) on September 10, 2026; holds 56,450 after (Direct).
- Option exercise/conversion: disposed of 8,000 Stock Option (Right to Buy) on September 10, 2026; holds 15,000 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,149,084 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Anne Lesage — Officer (Chief Early Development)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Option exercise/conversion | Common Stock | 30,000 | $8 | $241.5K | 86,450 |
| 2026-09-10 | Open-market sale | Common Stock | 30,000 | $38 | $1.1M | 56,450 |
| 2026-09-10 | Option exercise/conversion | Stock Option (Right to Buy) | 8,000 | — | — | 15,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Option exercise/conversion (30,000 shares) |
| 2026-09-10 | Open-market sale (30,000 shares) |
| 2026-09-10 | Option exercise/conversion (8,000 shares) |
Keywords
insider transaction, Form 4, PHVS, Pharvaris N.V., bearish, Anne Lesage
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.